These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Review of materials of VI International Conference "Options for the Control for Influenza"]. Nekrasov AV; Puchkova NG Zh Mikrobiol Epidemiol Immunobiol; 2008; (3):115-20. PubMed ID: 18595477 [No Abstract] [Full Text] [Related]
6. [A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Slepushkin AN; Obrosova-Serova NP; Burtseva EI; Govorkova EA; Rudenko LG; Vartanian RV; Vereshchinskiĭ AI; Musina MD; Lonskaia NI; Zazimko LA Vopr Virusol; 1991; 36(5):372-4. PubMed ID: 1803766 [TBL] [Abstract][Full Text] [Related]
7. Trends in development of the influenza vaccine with broader cross-protection. Stropkovská A; Janulíková J; Varecková E Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609 [TBL] [Abstract][Full Text] [Related]
8. Current and next generation influenza vaccines: Formulation and production strategies. Soema PC; Kompier R; Amorij JP; Kersten GF Eur J Pharm Biopharm; 2015 Aug; 94():251-63. PubMed ID: 26047796 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and effectiveness of virosomal adjuvanted vaccines against influenza: a brief review of their utility in the elderly population. Zamparo E; Little D J Prev Med Hyg; 2011 Sep; 52(3):116-9. PubMed ID: 22010538 [TBL] [Abstract][Full Text] [Related]
11. [Progress in new vaccine strategies against influenza: a review]. Liu Z; Jiang T; Qin E; Ran D; Qin C Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493 [TBL] [Abstract][Full Text] [Related]
12. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]
13. Influenza: girding for disaster. Facing down pandemic flu, the world's defenses are weak. Kaiser J Science; 2004 Oct; 306(5695):394-7. PubMed ID: 15486267 [No Abstract] [Full Text] [Related]
15. [The substances active against influenza virus. Possibilities and prospects of application]. Kwiatek M; Kocik J; Bartoszcze M Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of seasonal influenza vaccines: composition and properties]. Allwinn R; Doerr HW Dtsch Med Wochenschr; 2011 Nov; 136(45):2315-8. PubMed ID: 22048938 [TBL] [Abstract][Full Text] [Related]
19. Influenza: girding for disaster. Searching for all-powerful flu weapons. Kaiser J Science; 2004 Oct; 306(5695):395. PubMed ID: 15486268 [No Abstract] [Full Text] [Related]
20. Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza. Wong JP; Christopher ME; Viswanathan S; Schnell G; Dai X; Van Loon D; Stephen ER Expert Rev Respir Med; 2010 Apr; 4(2):171-7. PubMed ID: 20406083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]